Meta Faces EU Probe For Suspected Failure To Combat Russian Disinformation
Mon, Apr 29, 2024 7:37 PM

Meta Faces EU Probe For Suspected Failure To Combat Russian Disinformation

A Flip by Avya Verma
Get it on Google Play
European Commission reportedly plans to investigate Meta Platforms Inc’s META Facebook and Instagram over concerns regarding Russia disinformation, with suspicions of inadequate moderation. Regulators are alarmed by Meta’s purportedly insufficient efforts to combat political advertising disinformation, risking electoral integrity, according to a report from Financial Times.

More great flips

Mutual funds take Rs 10k cr contra bet on sleeping giants Kotak, HDFC Bank

Mutual funds take Rs 10k cr contra bet on sleeping giants Kotak, HDFC Bank

Braving all the bear howling, mutual funds spent close to Rs 10,000 crore to buy shares of Kotak Mahindra Bank and HDFC Bank in April. The two biggest wealth creators in the history of Dalal Street are now among the biggest Nifty losers in 2024. 📌MFs took advantage of the 9% dip in Kotak shares last month to buy 4.65 crore shares. 📌In the case of HDFC Bank, MFs bought 1.22 crore shares.

Open Flip
Apurva Sahijwani joins Avendus Wealth as MD and CEO

Apurva Sahijwani joins Avendus Wealth as MD and CEO

Avendus Wealth Management has named Apurva Sahijwani as its new managing director and CEO. Sahijwani, with extensive experience in the financial sector, will oversee the wealth team and utilize Avendus's platform to offer comprehensive advice to clients. Previously, he led Burgundy Private at Axis Bank and held various managerial roles at Kotak Wealth, ICICI Bank, HSBC, and Citibank.

Open Flip
Mankind Pharma: Strong Q4, Acquisition Reports Not Enough To Power Stock

Mankind Pharma: Strong Q4, Acquisition Reports Not Enough To Power Stock

Shares of Mankind Pharma were dipping on Thursday despite posting sharp growth in its bottom line for the fourth quarter amid speculation of a major acquisition. Mankind Pharma reported a net profit of ₹477 crore for the March quarter, marking a 62.3% increase from ₹294 crore in the same quarter last year. The Delhi-based pharmaceutical company’s revenue rose by 18.9%.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon